Delivery Order SPE2DB22D3301-SPE2DB24FY0CN

Award Date 2/5/24
Potential Completion Date 2/6/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,406.73 firm fixed-price delivery order is for the supply of 60 gram tubes of Calcipotriene 0.005% cream. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,208.34 firm fixed-price contract is for the delivery of Calcipotriene 0.005% Cream, a specialty medication, with a performance period ending on January 3, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,956.86 firm fixed-price delivery order is for the supply of Calcipotriene 0.005% Cream, a specialty pharmaceutical product, with a performance period through November 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of Calcipotriene 0.005% Cream in a 60-gram quantity. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $1,998.67 and an ultimate completion date of December 19, 2024. The contract was not set aside for any specific business classification....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Calcipotriene 0.005% Cream 60GM. The fixed-price contract has a ceiling value of $1,212.94 and a completion date of October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of Calcipotriene 0.005% cream in 60 gram tubes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, through its Corporate Office division located in Conshohocken, Pennsylvania. The contract is a firm fixed price delivery order with a ceiling value of $2,153.92 and a performance period ending on April 5, 2024. It is...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,524.40, is for the delivery of Calcipotriene 0.005% Solution, a topical medication, with an ultimate completion date of April 2, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of Calcipotriene 0.005% Cream 60GM to the Defense Logistics Agency (DLA). The $1,078.78 Firm Fixed Price delivery order was issued under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,751.96 firm fixed-price delivery order is for the supply of CALCIPOTRIENE 0.005% SOLUTION 60ML, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,743.82 firm-fixed-price delivery order is for the supply of Calcipotriene 0.005% Solution 60ML, a prescription medication. The contract has a period of performance ending on September 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY0CN
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is a $2,166.76 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Calcipotriene 0.005% Cream in 60 gram quantities. The delivery order has a completion date of February 6, 2024 and was awarded on February 5, 2024. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA for the provision of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC has a potential value of $999,999,999.00 and a performance period through December 31, 2025. No set-aside designations were used for this particular delivery order or the broader IDC contract.

Generated 5/6/24, 9:08 AM